Ronald Richard - Nov 25, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Nov 25, 2022
Transactions value $
-$22,829
Form type
4
Date filed
11/29/2022, 02:26 PM
Previous filing
May 31, 2022
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$22.8K -1.91K -8.79% $11.94 19.8K Nov 25, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.